Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record.

Selective Inhibitors of Ca2+-Binding Modulator of Phosphodiesterase Produce Vascular Relaxation and Inhibit Actin-Myosin Interaction

HIDAKA, HIROYOSHI, YAMAKI, TOKUO, TOTSUKA, TSUYOSHI, ASANO, MASAHISA · 1979 · Molecular Pharmacology

Abstract

To elucidate the role of Ca 2+ -regulated activator protein (a protein modulator) of cyclic nucleotide phosphodiesterase in smooth muscle contraction, we determined the effects of various drugs that selectively inhibit a protein modulator-induced stimulation of cyclic nucleotide phosphodiesterase on contractile response of isolated rabbit aortic strip, and superprecipitation of bovine aorta smooth muscle actomyosin, considered to be an in vitro analogue of muscle contraction. Actomyosin preparation from bovine aorta smooth muscle contained approximately 200 units (2 µg) of protein modulator per mg actomyosin and superprecipitated by addition of ATP. Selective inhibitors of the stimulation of the phosphodiesterase by a protein modulator such as N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) and its derivatives, or psychotropic agents such as chlorpromazine, chlorprothixene, amitriptyline and desipramine produced relaxation of isolated aortic strips contracted by various agonists such as KCl, CaCl 2 , norepinephrine, histamine, and prostaglandin F 2α . The relaxation induced by these agents was not affected by treatment with adrenergic or cholinergic blocking agents such as propranolol and atropine, suggesting that such do not work through these receptors. These drugs not only reduced the extent of actomyosin superprecipitation but also prolonged the time required to attain the maximum superprecipitation, suggesting that they inhibit the superprecipitation of aorta smooth muscle actomyosin. The addition of various amounts of protein modulator prevented in dose-dependent fashion the inhibition by these compounds of actomyosin superprecipitation. The order of the potency of the drugs was much the same in assay systems such as inhibiting the stimulation of the phosphodiesterase by a protein modulator, superprecipitation of actomyosin and producing a relaxation of aortic strip. Other vasodilating drugs such as isoproterenol, sodium nitrite and fusaric acid had no effect on smooth muscle contraction process (superprecipitation of actomyosin). Papaverine, which is a potent inhibitor of cyclic nucleotide phosphodiesterase and not a selective inhibitor, served also as the control. However, even papaverine failed to inhibit the superprecipitation. Our results provide pharmacological evidence that a protein modulator participates in the regulation in smooth muscle contraction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0026-895x(25)11550-2

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 196

Metadata

Authors
HIDAKA, H., YAMAKI, T., TOTSUKA, T., & ASANO, M.
Venue
Molecular Pharmacology
Publisher
Elsevier BV
Published
1979-01
Volume
15
Issue
1
Pages
49-59
ISSN
0026-895X (ISSN-L)
OpenAlex
W2470869994
Cited by
196
References
0
FWCI
8.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective Inhibitors of Ca2+-Binding Modulator of Phosphodiesterase Produce Vascular Relaxation and Inhibit Actin-Myosin Interaction. https://app.cochat.ai/papers/10.1016/s0026-895x(25)11550-2
The paper
HIDAKA, H., YAMAKI, T., TOTSUKA, T., & ASANO, M. (1979). Selective Inhibitors of Ca2+-Binding Modulator of Phosphodiesterase Produce Vascular Relaxation and Inhibit Actin-Myosin Interaction. Molecular Pharmacology. https://doi.org/10.1016/s0026-895x(25)11550-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.